Save time and get answers to complex questions with AI chat
Diltiazem drug class?Abbvie humira patent cliff navigation success?Sun pharma bortezomib?How long have hydroxyzine pamoate been on the market?When is xarelto's patent set to expire roughly?
See the DrugPatentWatch profile for cosentyx
In general, Cosentyx (secukinumab) does not require routine cardiac tests as part of starting therapy. What is commonly done (not strictly “cardiac tests,” but part of safety screening): - TB screening before starting (tuberculin skin test or IGRA) - Hepatitis B and C screening if indicated by risk factors - Basic safety labs or prior medical history review as needed (not mandated specifically for the heart) When a cardiac test might be considered: - If you have known heart disease or symptoms suggestive of heart problems (chest pain, shortness of breath, palpitations, significant fatigue), your clinician may evaluate your heart health and may order tests such as an ECG or echocardiogram or monitor you more closely. - Secukinumab carries a caution regarding heart failure; your doctor may be more vigilant if you have a history of heart failure or other cardiovascular issues. What to do: - Tell your doctor about any heart conditions, past heart procedures, chest pain, or shortness of breath. - Ask directly if you should have any cardiac testing before or during Cosentyx therapy given your personal health history. If you’d like, tell me about any heart conditions you have or medications you’re taking, and I can help summarize what questions to ask your doctor. This information is not a substitute for medical advice—please consult your healthcare provider for personalized recommendations.
Other Questions About Cosentyx :